Tag Archives: Mark S. Hanley

Mark H pics 012

CRA's CEO Wins Gold Stevie Award

Mark S. Hanley, Chief Executive Officer of Clinical Research Advantage, Inc. (CRA), was the recipient of a Gold Stevie® Award in this year’s American Business Awards. Hanley was recognized as the “Maverick of the Year” in the Business Services category.

Hanley was honored for his innovative vision and leadership, which included acquiring Radiant Research in 2012 to create the country’s largest and most therapeutically diverse integrated network of clinical trial sites. “It is an honor to receive this award,” said Hanley. “But, this is really an award for the entire CRA team. It is through all of their hard work and dedication that we have accomplished so much in the past 12 months.”

The American Business Awards are the nation’s premier business awards program. All organizations operating in the U.S.A. are eligible to submit nominations – public and private, for-profit and non-profit, large and small. Stevie Award winners were selected by more than 320 executives nationwide who participated in the judging process this year.

Nicknamed the Stevies for the Greek word for “crowned,” the 11th annual award ceremony was held on June 17th in Chicago, Illinois. This year, the judges reviewed more than 3,200 nominations from organizations of all sizes and virtually every industry.

 

Mark H pics 012

CRA’s CEO Wins Gold Stevie Award

Mark S. Hanley, Chief Executive Officer of Clinical Research Advantage, Inc. (CRA), was the recipient of a Gold Stevie® Award in this year’s American Business Awards. Hanley was recognized as the “Maverick of the Year” in the Business Services category.

Hanley was honored for his innovative vision and leadership, which included acquiring Radiant Research in 2012 to create the country’s largest and most therapeutically diverse integrated network of clinical trial sites. “It is an honor to receive this award,” said Hanley. “But, this is really an award for the entire CRA team. It is through all of their hard work and dedication that we have accomplished so much in the past 12 months.”

The American Business Awards are the nation’s premier business awards program. All organizations operating in the U.S.A. are eligible to submit nominations – public and private, for-profit and non-profit, large and small. Stevie Award winners were selected by more than 320 executives nationwide who participated in the judging process this year.

Nicknamed the Stevies for the Greek word for “crowned,” the 11th annual award ceremony was held on June 17th in Chicago, Illinois. This year, the judges reviewed more than 3,200 nominations from organizations of all sizes and virtually every industry.

 

DBruggeman

CRA President Receives Stevie Awards

David M. Bruggeman, President and Chief Operating Officer of Clinical Research Advantage, Inc. (CRA), was the recipient of two Stevie Awards at the 11th annual American Business Awards. Bruggeman received the Bronze Award for “Executive of the Year” in both the Pharmaceuticals and Health Products and Services categories.

Bruggeman was recognized for his ingenuity and leadership in building the country’s largest integrated network of clinical trial sites and partnering with Quintiles to create the first-ever therapeutic alliance for clinical trials in primary medicine. “David is an extraordinary leader whose work has improved the quality and efficiency of the clinical research process,” said Mark S. Hanley, CRA’s Chief Executive Officer. “We are happy to hear that David has received this national honor.”

The American Business Awards are the nation’s premier business awards program. All organizations operating in the U.S.A. are eligible to submit nominations – public and private, for-profit and non-profit, large and small. Stevie Award winners were selected by more than 320 executives nationwide who participated in the judging process this year.

Nicknamed the Stevies for the Greek word for “crowned,” the awards were held on June 17th in Chicago, Illinois. This year, the judges reviewed more than 3,200 nominations from organizations of all sizes and virtually every industry.

sleep

S.T.A.R.S. Receives Gold Best in Biz Award

Sleep Testing and Respiratory Services (S.T.A.R.S.) received top honors in this year’s Best in Biz Awards, the only independent business awards program judged by members of the press and industry analysts. The company’s Director of Human Resources, Kara Chase, was honored with a Gold Best in Biz Award for Human Resources Executive of the Year.

Chase was recognized for her integral role in the 2011 S.T.A.R.S. asset purchase, and for her leadership and management as head of Human Resources for S.T.A.R.S. and its sister companies, Heartland Health and Clinical Research Advantage.

“Kara Chase has been instrumental in the success of S.T.A.R.S., Heartland Health and Clinical Research Advantage,” said Mark S. Hanley, Chief Executive Officer of S.T.A.R.S. “She was responsible for leading a series of initiatives to safeguard each company as it grew. This enabled us to manage our unprecedented growth while upholding our high standards for quality and service.”

More than 400 entries were received in this year’s awards program, from a wide array of public and private companies of all sizes and from a variety of industries and regions in the U.S. and Canada.

Winners of Best in Biz Awards 2012 were determined by an independent panel of 32 judges from top-tier news, business and technology publications, as well as broadcast outlets and analyst firms, such as ABC, Businessweek, Computerworld, ECT News Network, Entrepreneur, eWeek, Examiner, Financial Times, Forbes, FOX News, Hartford Business Journal, IDG Ventures, IEEE Institute, Inc., Insight Media, King Features Syndicate, Lab Reviews, Network World, The News and Observer, PC Magazine, ReadWriteWeb, South Florida Business Journal, Tech-Gaming, Techtalk, Upstart Business Journal, USA Today and ZDNet.

Orvin & Drake

CRA Receives Gold Best in Biz Award

Clinical Research Advantage (CRA) received top honors in this year’s Best in Biz Awards, the only independent business awards program judged by members of the press and industry analysts. CRA received the Gold Award for Business Development Department of the Year.

Casey Orvin, Vice President of Business Development, and Amanda Drake, Director of Business Development, were recognized for their achievements in helping the company grow to become the largest and most therapeutically diverse integrated site network in the clinical trials industry.

“Casey Orvin and Amanda Drake have been vital to CRA’s substantial growth over the past couple of years,” said Mark S. Hanley, the company’s Chief Executive Officer. “Through their efforts, the number of clinical trials conducted by CRA increased by nearly 150%, and it continues to grow at an unprecedented rate.”

More than 400 entries were received in this year’s awards program, from a wide array of public and private companies of all sizes and from a variety of industries and regions in the U.S. and Canada.

Winners of Best in Biz Awards 2012 were determined by an independent panel of 32 judges from top-tier news, business and technology publications, as well as broadcast outlets and analyst firms, such as ABC, Businessweek, Computerworld, ECT News Network, Entrepreneur, eWeek, Examiner, Financial Times, Forbes, FOX News, Hartford Business Journal, IDG Ventures, IEEE Institute, Inc., Insight Media, King Features Syndicate, Lab Reviews, Network World, The News and Observer, PC Magazine, ReadWriteWeb, South Florida Business Journal, Tech-Gaming, Techtalk, Upstart Business Journal, USA Today and ZDNet.

Mark H pics 001

CRA forms alliance with Quintiles

Tempe-based Clinical Research Advantage (CRA), the country’s largest community-based network of clinical trial sites, has entered into a strategic agreement  with Quintiles to facilitate a higher level of clinical trial participation with an emphasis on safety, improved study efficiencies and excellent quality data in medical research. Clinical Research Advantage is the first therapeutically aligned network of Family Medicine community-based sites selected by Quintiles as a strategic alliance.

“It is an honor to be chosen by Quintiles, the world’s largest biopharmaceutical services provider with the highest standards for quality and safety,” said Mark S. Hanley, CRA’s Chief Executive Officer. “The core value and principal purpose of Clinical Research Advantage is to improve the lives of patients through the development of new medical therapies. Working with Quintiles will allow CRA to conduct an increased number of community-based trials with unparalleled accuracy and safety.”

“Clinical Research Advantage impressed us with their high standards for quality, high patient enrolments, and exceptional study start-up abilities,” said Lindy Jones, Senior Vice President, Integrated Site Services, Quintiles. “Many chronic conditions such as diabetes and heart disease are now managed in the community. It is imperative that these patient populations have the opportunity to participate in studies and be a part of the quest to develop new and better medicines for conditions that have a significant impact on both individuals and society.  We are pleased to enter into this relationship with CRA and anticipate that together we will ensure that studies start on the right path.”

The CRA-Quintiles relationship marks a new era in Phase II – IV clinical trials, enabling physicians and clinical researchers to conduct an increased number of trials across a wide range of disease areas. In addition, it will streamline and expedite the process of bringing these potentially life-changing and life-saving drugs to market.
About Clinical Research Advantage

Tempe, Arizona-based Clinical Research Advantage, Inc. (CRA) is a provider of a range of research services to pharmaceutical companies and clinical research organizations. As a leading trial management organization, CRA operates from 38 sites across 17 geographic markets nationwide, helping trial sponsors bring drugs to market more quickly and efficiently. Founded in 1992, CRA has successfully completed more than 1,800 clinical trials on behalf of its clients. For more information, please visit www.crastudies.com.

4692_CRA_f

Clinical Research Advantage VP earns Silver Stevie

Kim Kundert, RN, BSN, CCRC, has received the 2012 Silver Stevie Award for Female Executive of the Year in the Business Services category. Kundert was honored for her achievements as Vice President of Clinical Operations for Clinical Research Advantage, an integrated network of clinical trial sites.

The Stevie Awards for Women in Business are the world’s top honors for female entrepreneurs, executives, and the organizations they run. All individuals and organizations worldwide are eligible to submit nominations – public and private, for-profit and non-profit, large and small. The 2012 awards received entries from 17 nations and territories.

Stevie Award winners were selected by more than 200 executives worldwide who participated in the judging process this year.

“In 2012, Clinical Research Advantage became the largest integrated site network in the United States, and Kim Kundert has been a driving force behind the company’s rapid growth and expansion. We are thrilled that she has received national recognition for her executive leadership,” said Mark S. Hanley, CEO of Clinical Research Advantage.

This year marked the 9th Annual Celebration of the Stevie Awards for Women in Business. “This year’s Stevie Award-winning women are the most accomplished, impressive group we’ve ever had. Their stories of success will be an inspiration to women around the globe who dream of starting and growing a business and making a difference in the world,” said Michael Gallagher, president and founder of the Stevie Awards.